Free Trial

NanoVibronix (NAOV) Competitors

NanoVibronix logo
$0.50 0.00 (-0.20%)
As of 01/21/2025 04:00 PM Eastern

NAOV vs. STRR, TTOO, PSTV, PAVM, INBS, TNON, SINT, NUWE, STSS, and HSCS

Should you be buying NanoVibronix stock or one of its competitors? The main competitors of NanoVibronix include Star Equity (STRR), T2 Biosystems (TTOO), Plus Therapeutics (PSTV), PAVmed (PAVM), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Sintx Technologies (SINT), Nuwellis (NUWE), Sharps Technology (STSS), and Heart Test Laboratories (HSCS). These companies are all part of the "medical equipment" industry.

NanoVibronix vs.

Star Equity (NASDAQ:STRR) and NanoVibronix (NASDAQ:NAOV) are both small-cap multi-sector conglomerates companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

In the previous week, Star Equity's average media sentiment score of 0.00 equaled NanoVibronix'saverage media sentiment score.

Company Overall Sentiment
Star Equity Neutral
NanoVibronix Neutral

Star Equity has a net margin of -12.41% compared to NanoVibronix's net margin of -93.80%. Star Equity's return on equity of -8.72% beat NanoVibronix's return on equity.

Company Net Margins Return on Equity Return on Assets
Star Equity-12.41% -8.72% -4.62%
NanoVibronix -93.80%-101.17%-53.03%

3.8% of Star Equity shares are owned by institutional investors. Comparatively, 16.4% of NanoVibronix shares are owned by institutional investors. 33.5% of Star Equity shares are owned by insiders. Comparatively, 4.2% of NanoVibronix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Star Equity has higher revenue and earnings than NanoVibronix. Star Equity is trading at a lower price-to-earnings ratio than NanoVibronix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Star Equity$45.78M0.16$25.13M-$2.57-0.86
NanoVibronix$2.28M0.82-$3.71M-$1.23-0.41

NanoVibronix received 68 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 57.26% of users gave NanoVibronix an outperform vote.

CompanyUnderperformOutperform
Star EquityOutperform Votes
3
100.00%
Underperform Votes
No Votes
NanoVibronixOutperform Votes
71
57.26%
Underperform Votes
53
42.74%

Star Equity has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Comparatively, NanoVibronix has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500.

Summary

Star Equity beats NanoVibronix on 7 of the 13 factors compared between the two stocks.

Get NanoVibronix News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAOV vs. The Competition

MetricNanoVibronixSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$1.87M$10.12B$5.39B$9.13B
Dividend YieldN/A1.36%5.37%4.00%
P/E Ratio-0.4118.3289.0817.53
Price / Sales0.8227.601,255.34136.91
Price / CashN/A24.6436.6032.90
Price / Book0.265.834.964.69
Net Income-$3.71M$177.36M$117.89M$224.57M
7 Day Performance-12.46%2.72%1.72%1.69%
1 Month Performance-14.00%7.84%3.66%5.34%
1 Year Performance-41.29%-4.35%25.79%21.47%

NanoVibronix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAOV
NanoVibronix
0.3496 of 5 stars
$0.50
-0.2%
N/A-44.5%$1.87M$2.28M-0.4120Gap Down
STRR
Star Equity
N/A$2.19
-1.4%
N/A-54.9%$7.05M$45.78M-0.85460Gap Up
TTOO
T2 Biosystems
1.6614 of 5 stars
$0.32
flat
$5.00
+1,462.5%
-94.8%$6.73M$7.68M0.00180Analyst Forecast
News Coverage
Gap Up
PSTV
Plus Therapeutics
2.0756 of 5 stars
$1.14
-1.7%
$13.50
+1,084.2%
-42.3%$6.73M$4.91M-0.4520Positive News
PAVM
PAVmed
4 of 5 stars
$0.60
-1.3%
$19.00
+3,066.7%
-76.1%$6.64M$4.03M-0.1490News Coverage
Positive News
INBS
Intelligent Bio Solutions
1.4072 of 5 stars
$1.32
-0.8%
N/A-64.6%$5.79M$3.19M0.0010Short Interest ↓
News Coverage
Positive News
TNON
Tenon Medical
2.3662 of 5 stars
$1.73
-6.0%
$5.50
+217.9%
+29.9%$5.43M$3.32M-0.068
SINT
Sintx Technologies
0.0755 of 5 stars
$3.36
-0.9%
N/A-94.6%$4.51M$1.64M-0.0740Positive News
Gap Down
NUWE
Nuwellis
2.9051 of 5 stars
$1.01
-1.0%
$17.00
+1,583.2%
-92.5%$4.42M$8.97M-0.0170
STSS
Sharps Technology
0.7426 of 5 stars
$2.02
-1.9%
N/AN/A$4.13MN/A-0.253
HSCS
Heart Test Laboratories
2.1279 of 5 stars
$3.22
-5.3%
$13.50
+319.3%
-70.7%$3.16M$14,700.00-0.1510Short Interest ↑
Positive News

Related Companies and Tools


This page (NASDAQ:NAOV) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners